Silberman Allan W MD is categorized under Physicians Offices in Los Angeles, CA and active since 2007.
Silberman Allan W MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Allan Silberman at the company’s single location by writing to 8700 Beverly Boulevard, Los Angeles, California CA 90048 or by phoning (310) 423-5470. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Silberman Allan W MD |
| Contact Person: | Allan Silberman |
| Address: | 8700 Beverly Boulevard, Los Angeles, California 90048 |
| Phone Number: | (310) 423-5470 |
| Website Address: | cedars-sinai.edu |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Silberman Allan W MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Allan Silberman for inquiries that concern Silberman Allan W MD by calling the company number (310) 423-5470, as your correspondence is most welcome. Additionally, the physical location of the single location of Silberman Allan W MD can be found at the coordinates 34.07673,-118.38007 as well as the street address 8700 Beverly Boulevard in Los Angeles, California 90048.
For its online presence, you may visit Silberman Allan W MD’s website at cedars-sinai.edu and engage with its social media outlets through on Twitter and on Facebook.